LianBio Profile Avatar - Palmy Investing

LianBio

LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treat…

Biotechnology
US, Princeton [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of LIAN's Analysis
CIK: 1831283 CUSIP: - ISIN: US53000N1081 LEI: - UEI: -
Secondary Listings
LIAN has no secondary listings inside our databases.